For The Better

AMD shares have been on fire this year.

Oracle’s Project Jupiter could fail — and it’s not even Oracle’s fault.

Centrus is securing deals to supply the fuel powering the next generation of nuclear reactors.

VanEck’s concentrated 25-stock biotech portfolio surged 40.5% in one year, but Fidelity’s diversified 365-holding fund delivered superior risk-adjusted returns with half the volatility.

CrowdStrike trades at a premium valuation despite lingering reputational damage, while Figma’s growth outpaces profitability by a wide margin.

Long-term investors shouldn’t fear a bear market.

Orders expected by year-end as Georgia facility ramps production.

NuScale Power has irons in the fire, but it is still in the very early stages of its development as a business.

You’ll pay more now for Disney+ and Hulu. There’s a good reason you will keep paying.

If you’re looking for an income investment to plug into for more than a few years, take a step back and look at the longer-term math.

AT&T’s net margin nearly doubled year-over-year, while Verizon carries higher debt but generated stronger free cash flow.

The next bear market may be your best opportunity to grow your portfolio.

Revenue growth returned amid higher acquisition costs and consumer headwinds.

AI-powered payroll automation and PEO conversions drive 14% operating income growth.

Record margins and raised guidance as revenue tops $3 billion.